Scotch Corner IPO: What You Should Know Key Project Information Overview

Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

Cizzle Biotechnology to issue shares following £400,000 CLN conversion

Cizzle Biotechnology will issue 28,571,429 new ordinary shares after receiving a conversion notice for £400,000 of convertible loan notes held by Frazer Lang...

May 6, 2026

Atlantic AI Summit adds AI ethics and healthcare innovation keynote

The 2026 Atlantic AI Summit has named Dr Michael M Karch as a keynote speaker, with a focus on AI readiness, ethics, and leadership...

May 1, 2026

Genflow Biosciences delivers strong 2025 progress across key programs

Genflow Biosciences’ 2025 results highlight strong operational progress, including a major milestone in its dog aging study, advancement of its MASH program toward clinical readiness, expanded global patent protection, and..

May 1, 2026

Cizzle Biotechnology 2025 results highlight licensing and clinical progress

Cizzle Biotechnology has released its Annual Report for the year ended 31 December 2025, outlining progress toward commercialising its early lung cancer blood test and detailing financial results, partnerships, and..

April 30, 2026

Verici Dx shows stronger signs of commercial adoption

Verici Dx is building commercial momentum as Tutivia gains repeat use across US kidney transplant centres...

April 28, 2026

Verici Dx Shows Strong Momentum with Impressive Q1 Growth, Singer Capital Markets

Verici Dx reports strong Q1 growth with rising Tutivia adoption, expanding transplant centre reach and positive outlook from Singer Capital Markets research note...

April 28, 2026

Genflow Biosciences expands animal health partnerships for canine gene therapy review

Genflow Biosciences has signed additional confidentiality agreements with leading animal health companies to evaluate data from its canine SIRT6 gene therapy programme, following positive preliminary results...

April 28, 2026

Biotechnology: A sector built around practical scientific innovation

Biotechnology turns biological science into practical products, creating investment opportunities shaped by innovation, risk and commercial execution...

April 27, 2026

Smith & Nephew to host Surgeon Insights event in London

Smith & Nephew will host an investor event in London featuring US surgeons discussing innovation platforms across sports medicine, wound care, and orthopaedics, with presentations and Q&A sessions led by..

April 27, 2026

FDA approves AstraZeneca’s Saphnelo Pen for self-administration in SLE

AstraZeneca’s Saphnelo has received US approval as a once-weekly autoinjector for adults with systemic lupus erythematosus, offering a self-administered alternative to IV infusion...

April 27, 2026

Gene therapy enters a more practical phase for biotech tnvestors

Gene therapy is moving closer to practical use, with Genflow’s delivery strategy and rare disease focus offering investors a clearer view of how scientific progress may translate into commercial opportunity...

April 24, 2026

Hikma reports solid start to 2026, maintains full-year outlook

Ahead of its Annual General Meeting, Hikma said all three businesses are performing well, announced a device partnership to support its generic Ellipta programme, and confirmed its 2026 revenue and..

April 23, 2026

Genflow Biosciences’ Dr Eric Leire highlights funding, pipeline progress and near-term catalysts

CEO Dr. Eric Leire discusses progress across Genflow’s dog study, glaucoma and sarcopenia programmes, recent grant funding, large market opportunities and upcoming milestones, including clinical results, partnering discussions and patent..

April 22, 2026

Verici Dx gains commercial momentum as Tutivia adoption builds

Commercial uptake of Verici Dx’s Tutivia test is accelerating, giving investors firmer evidence that adoption and reimbursement momentum may now be building together...

April 22, 2026

GenFlow Biosciences sharpens its longevity strategy

GenFlow Biosciences is making its longevity strategy more investable by backing the science with practical choices on manufacturing, platform design and regulatory progress...

April 20, 2026

Third positive Phase III trial supports AstraZeneca’s tozorakimab in COPD

High-level data from the MIRANDA study showed AstraZeneca’s IL-33-targeting biologic tozorakimab significantly lowered annualised moderate-to-severe COPD exacerbations and was generally well tolerated...

April 20, 2026

GSK wins China approval for Blenrep in previously treated multiple myeloma

The approval covers Blenrep plus bortezomib and dexamethasone for adults with relapsed or refractory multiple myeloma and is supported by phase III DREAMM-7 data showing progression-free and overall survival benefits...

April 20, 2026

Genflow Biosciences partners with Acuitas to advance SIRT6 mRNA programme

Genflow Biosciences has entered a fully funded collaboration with Acuitas Therapeutics to apply lipid nanoparticle delivery technology to its SIRT6 mRNA platform, supporting preclinical development for age-related diseases...

April 20, 2026

Physicians Capital: Why Dr. Conrad Ivie Believes Doctors Must Reclaim Ownership Before Burnout Wins (video)

April 17, 2026

News and Interview Alerts

Company Presentations

Time Finance Profits Surge, Book Grows 86% as New Strategy Targets £300m Lending

Q&As

Time Finance’s Ed Rimmer highlights importance of cash flow planning for SMEs

1 May 2026

Arbuthnot Banking Group set for profit stability as credit quality improves (LON:ARBB)

1 May 2026

Hardman & Co

Chesnara Plc: Showing good operational progress

17 April 2026

Arbuthnot Banking Group Plc: 2025 lower margins, 2026 profit stability

1 April 2026

ICG Enterprise Trust Shareholder seminar 2026: resilience and growth

18 March 2026

Green News

Ferro-Alloy Resources Progresses Balasausqandiq Development as Panmure Liberum Maintains BUY Rating

7 May 2026

Drax maintains 2026 outlook amid strong operations and UK energy investments

30 April 2026

Diversified Energy to announce first quarter 2026 results on May 6th

30 April 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

Chesnara: Why Two Deals Are Reshaping Cash Generation and Dividend Confidence (video)

Volta Finance: Structural Strengths Shield Against Market Stress (video)

Physicians Capital: Why Dr. Conrad Ivie Believes Doctors Must Reclaim Ownership Before Burnout Wins (video)

BrokerTalk

Hercules launches dedicated Power & Energy Services division to target UK infrastructure investment

3 August 2026

Avingtrans Plc sees strong long-term growth potential in latest Cavendish note

3 August 2026

Avingtrans Plc sees strong progress and margin improvement in latest Cavendish research note

3 August 2026

Avingtrans Plc latest research note highlights progress and growth potential from Cavendish

3 August 2026

Billington Holdings wins three new contracts worth £28m, says Cavendish

3 August 2026

Funds

Biotech Growth Trust outperforms benchmark in April

26 May 2026

Diverse Income Trust reports strong April performance

26 May 2026

Diverse Income Trust declares 3.05p interim dividend

21 May 2026

BlackRock Frontiers Investment Trust (LON:BRFI)

BlackRock World Mining Trust highlights long-term commodity growth themes (LON:BRWM)

18 May 2026

Real Estate Credit Investments April NAV rises to 138.7p

18 May 2026

View all Funds, Market Insights and news >>

FTSE 100 News

Smiths lowers FY2026 revenue guidance after Middle East disruption

21 May 2026

Sage Group lifts FY26 outlook after strong first-half growth

21 May 2026

ICG reports strong FY26 results as fee-related earnings rise 23%

21 May 2026

Marks & Spencer FY2026 profit falls despite strong food performance

20 May 2026

UK Broker Ratings

BARR (A.G.) PLC (BAG.L) Stock Analysis: Navigating a 26.9% Upside Potential Amidst Challenging Valuations

26 May 2026

AVI Global Trust PLC ORD 2P (AGT.L): A Singular Buy Rating Signals Investor Confidence

26 May 2026

Hilton Food Group PLC (HFG.L) Investor Outlook: Potential Upside and Robust Dividend Yield

26 May 2026

Goodwin PLC (GDWN.L): A Strong Contender in Specialty Industrial Machinery with Impressive Revenue Growth

26 May 2026

Balfour Beatty PLC (BBY.L) Investor Outlook: Navigating a 14.62% Potential Upside Amidst Robust Revenue Growth

26 May 2026

Health

Cizzle Biotechnology to issue shares following £400,000 CLN conversion

Cizzle Biotechnology will issue 28,571,429 new ordinary shares after receiving a conversion notice for £400,000 of convertible loan notes held by Frazer Lang...

May 6, 2026

Atlantic AI Summit adds AI ethics and healthcare innovation keynote

The 2026 Atlantic AI Summit has named Dr Michael M Karch as a keynote speaker, with a focus on AI readiness, ethics, and leadership...

May 1, 2026

Genflow Biosciences delivers strong 2025 progress across key programs

May 1, 2026

Cizzle Biotechnology 2025 results highlight licensing and clinical progress

April 30, 2026

Verici Dx shows stronger signs of commercial adoption

Verici Dx is building commercial momentum as Tutivia gains repeat use across US kidney transplant centres...

April 28, 2026

Verici Dx Shows Strong Momentum with Impressive Q1 Growth, Singer Capital Markets

Verici Dx reports strong Q1 growth with rising Tutivia adoption, expanding transplant centre reach and positive outlook from Singer Capital Markets research note...

April 28, 2026

Genflow Biosciences expands animal health partnerships for canine gene therapy review

April 28, 2026

Biotechnology: A sector built around practical scientific innovation

Biotechnology turns biological science into practical products, creating investment opportunities shaped by innovation, risk and commercial execution...

April 27, 2026

Smith & Nephew to host Surgeon Insights event in London

April 27, 2026

FDA approves AstraZeneca’s Saphnelo Pen for self-administration in SLE

AstraZeneca’s Saphnelo has received US approval as a once-weekly autoinjector for adults with systemic lupus erythematosus, offering a self-administered alternative to IV infusion...

April 27, 2026

Gene therapy enters a more practical phase for biotech tnvestors

April 24, 2026

Hikma reports solid start to 2026, maintains full-year outlook

Ahead of its Annual General Meeting, Hikma said all three businesses are performing well, announced a device partnership to support its generic Ellipta programme, and confirmed its 2026 revenue and profit guidance remains unchanged...

April 23, 2026

Genflow Biosciences’ Dr Eric Leire highlights funding, pipeline progress and near-term catalysts

April 22, 2026

Verici Dx gains commercial momentum as Tutivia adoption builds

Commercial uptake of Verici Dx’s Tutivia test is accelerating, giving investors firmer evidence that adoption and reimbursement momentum may now be building together...

April 22, 2026

GenFlow Biosciences sharpens its longevity strategy

GenFlow Biosciences is making its longevity strategy more investable by backing the science with practical choices on manufacturing, platform design and regulatory progress...

April 20, 2026

Third positive Phase III trial supports AstraZeneca’s tozorakimab in COPD

April 20, 2026

GSK wins China approval for Blenrep in previously treated multiple myeloma

April 20, 2026

Genflow Biosciences partners with Acuitas to advance SIRT6 mRNA programme

April 20, 2026

Physicians Capital: Why Dr. Conrad Ivie Believes Doctors Must Reclaim Ownership Before Burnout Wins (video)

Dr. Conrad Ivie breaks down why more physicians are burning out while owning less of the healthcare system they power. From building Tennessee’s largest orthopaedic group to launching Physicians Capital, he explains why real estate, financial fluency and long-term ownership are becoming essential for doctors who want more than income tied to time...

April 17, 2026